Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 38194616

Adjuvant Abemaciclib Plus Endocrine Therapy for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative, High-Risk Early Breast Cancer: Results From a Preplanned monarchE Overall Survival Interim Analysis, Including 5-Year Efficacy Outcomes.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2024 Mar 20
First author
Rastogi P

This record carries publication-notice metadata. Review the notices below before relying on it.

Publication notices

absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2024 Jun 10;42(17):2111. doi: 10.1200/JCO.24.00711.
    note
    Source null
    related pmid
    38687953
    relationship
    Erratum in
  2. citation
    J Clin Oncol. 2025 Jan;43(1):113. doi: 10.1200/JCO-24-02469.
    note
    Source null
    related pmid
    39561312
    relationship
    Erratum in

Authors and identifiers

  1. name
    Rastogi P
    type
    Author
  2. name
    O'Shaughnessy J
    type
    Author
  3. name
    Martin M
    type
    Author
  4. name
    Boyle F
    type
    Author
  5. name
    Cortes J
    type
    Author
  6. name
    Rugo HS
    type
    Author
  7. name
    Goetz MP
    type
    Author
  8. name
    Hamilton EP
    type
    Author
  9. name
    Huang CS
    type
    Author
  10. name
    Senkus E
    type
    Author
  11. name
    Tryakin A
    type
    Author
  12. name
    Cicin I
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Rastogi P
    type
    Author
  2. name
    O'Shaughnessy J
    type
    Author
  3. name
    Martin M
    type
    Author
  4. name
    Boyle F
    type
    Author
  5. name
    Cortes J
    type
    Author
  6. name
    Rugo HS
    type
    Author
  7. name
    Goetz MP
    type
    Author
  8. name
    Hamilton EP
    type
    Author
  9. name
    Huang CS
    type
    Author
  10. name
    Senkus E
    type
    Author
  11. name
    Tryakin A
    type
    Author
  12. name
    Cicin I
    type
    Author
bibliography ids
  1. nci-bib-4079aa40603f4844c786ded1
book metadata
content sha256
e9972e0d7a914c44c337fb3d449dad24e58a92d9f3f7ba1b9045e6772b2f990f
document type
citation
dois
  1. 10.1200/JCO.23.01994
electronic publication date
display
2024 Jan 9
precision
day
year
2024
evidence scope
bibliographic_metadata_only
id
pubmed:38194616
immutable id
pubmed:38194616@e9972e0d7a914c44c337fb3d449dad24e58a92d9f3f7ba1b9045e6772b2f990f
journal
abbreviation
J Clin Oncol
issn electronic
1527-7755
issn print
0732-183X
issue
9
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
987-993
volume
42
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2024 Jun 10;42(17):2111. doi: 10.1200/JCO.24.00711.
    note
    Source null
    related pmid
    38687953
    relationship
    Erratum in
  2. citation
    J Clin Oncol. 2025 Jan;43(1):113. doi: 10.1200/JCO-24-02469.
    note
    Source null
    related pmid
    39561312
    relationship
    Erratum in
outcomes validated
false
pmid
38194616
provenance
batch id
6d213eecf21b6b7867cb
provider
NCBI PubMed ESummary
record sha256
818b2105e78c16529117a03a64816b95a338da278e9a81823d7b272e26c58948
response sha256
684f894a21d8f5f78a3bd0acd8ee4215ff94144487c53dab1056650ee8d6751d
retrieved at
2026-09-09T23:48:19.049083+00:00
publication date
display
2024 Mar 20
precision
day
year
2024
publication types
  1. Journal Article
  2. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/38194616/
title
Adjuvant Abemaciclib Plus Endocrine Therapy for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative, High-Risk Early Breast Cancer: Results From a Preplanned monarchE Overall Survival Interim Analysis, Including 5-Year Efficacy Outcomes.

Preserved source evidence · Not medical advice